205 related articles for article (PubMed ID: 31812654)
1. Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing.
Christensen B; Erlich J; Gibson PR; Turner JR; Hart J; Rubin DT
Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2518-2525.e1. PubMed ID: 31812654
[TBL] [Abstract][Full Text] [Related]
2. Ileal or Colonic Histologic Activity Is Not Associated With Clinical Relapse in Patients With Crohn's Disease in Endoscopic Remission.
Hu AB; Tan W; Deshpande V; Ananthakrishnan AN
Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1226-1233.e1. PubMed ID: 32360823
[TBL] [Abstract][Full Text] [Related]
3. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG
Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871
[TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of Histologic Abnormalities in Ileocolonic Biopsies of Patients With Crohn's Disease in Remission.
Brennan GT; Melton SD; Spechler SJ; Feagins LA
J Clin Gastroenterol; 2017 Jan; 51(1):43-48. PubMed ID: 26927490
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's Disease.
Wong ECL; Yusuf A; Pokryszka J; Dulai PS; Colombel JF; Marshall JK; Reinisch W; Narula N
Inflamm Bowel Dis; 2023 Jun; 29(6):875-882. PubMed ID: 35880680
[TBL] [Abstract][Full Text] [Related]
7. Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn's disease in clinical remission.
Takabayashi K; Hosoe N; Kato M; Hayashi Y; Nanki K; Fukuhara K; Mikami Y; Mizuno S; Sujino T; Mutaguchi M; Naganuma M; Yahagi N; Ogata H; Kanai T
J Gastroenterol; 2021 Jan; 56(1):25-33. PubMed ID: 33078323
[TBL] [Abstract][Full Text] [Related]
8. Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission.
Lin X; Qiu Y; Feng R; Chen B; He Y; Zeng Z; Zhang S; Chen M; Mao R
Clin Transl Gastroenterol; 2020 Feb; 11(2):e00135. PubMed ID: 32463625
[TBL] [Abstract][Full Text] [Related]
9. Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission.
Wang H; Fewings I; Bornman L; Shadbolt B; Fadia M; Subramaniam K
J Clin Gastroenterol; 2023 May-Jun 01; 57(5):494-500. PubMed ID: 35220375
[TBL] [Abstract][Full Text] [Related]
10. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P
Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
[TBL] [Abstract][Full Text] [Related]
11. Toward transmural healing: Sonographic healing is associated with improved long-term outcomes in patients with Crohn's disease.
Vaughan R; Tjandra D; Patwardhan A; Mingos N; Gibson R; Boussioutas A; Ardalan Z; Al-Ani A; Gibson PR; Christensen B
Aliment Pharmacol Ther; 2022 Jul; 56(1):84-94. PubMed ID: 35343603
[TBL] [Abstract][Full Text] [Related]
12. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K
Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
[TBL] [Abstract][Full Text] [Related]
13. Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
Löwenberg M; Vermeire S; Mostafavi N; Hoentjen F; Franchimont D; Bossuyt P; Hindryckx P; Rispens T; de Vries A; van der Woude CJ; Berends S; Ambarus CA; Mathot R; Clasquin E; Baert F; D'Haens G
Gastroenterology; 2019 Oct; 157(4):997-1006.e6. PubMed ID: 31175865
[TBL] [Abstract][Full Text] [Related]
14. Is histological healing more clinically valuable than endoscopic healing in Crohn's disease?
Zhang T; Zhang QD; Jin T; Li WJ; Wang HY; Lu XY; Li XQ; Liu SJ; Yang BL
Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1143-1148. PubMed ID: 37577787
[TBL] [Abstract][Full Text] [Related]
15. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease.
Ollech JE; Aharoni-Golan M; Weisshof R; Normatov I; Sapp AR; Kalakonda A; Israel A; Glick LR; Karrison T; Dalal SR; Sakuraba A; Cohen RD; Rubin DT; Pekow J
Gastrointest Endosc; 2019 Aug; 90(2):269-275. PubMed ID: 30738034
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.
Rath T; Atreya R; Bodenschatz J; Uter W; Geppert CE; Vitali F; Fischer S; Waldner MJ; Colombel JF; Hartmann A; Neurath MF
Gastroenterology; 2023 Feb; 164(2):241-255. PubMed ID: 36279923
[TBL] [Abstract][Full Text] [Related]
17. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
18. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
Peyrin-Biroulet L; Reinisch W; Colombel JF; Mantzaris GJ; Kornbluth A; Diamond R; Rutgeerts P; Tang LK; Cornillie FJ; Sandborn WJ
Gut; 2014 Jan; 63(1):88-95. PubMed ID: 23974954
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial.
Reinisch W; Colombel JF; D'Haens G; Sandborn WJ; Rutgeerts P; Geboes K; Petersson J; Eichner S; Zhou Q; Robinson AM; Read HA; Thakkar R
J Crohns Colitis; 2017 Apr; 11(4):425-434. PubMed ID: 27815351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
